Literature DB >> 10738923

Muscular carnitine palmitoyltransferase II deficiency in infancy.

H Hurvitz1, A Klar, I Korn-Lubetzki, R J Wanders, O N Elpeleg.   

Abstract

An 8-month-old female presented with febrile myoglobinuria. The activity of carnitine palmitoyltransferase (CPT) II was decreased to 16% of the control mean, and the oxidation of the long-chain fatty acids was reduced to 25% of the mean in the fibroblasts. Homozygosity for the common mutation, S113L, was identified in the CPT II gene. Residual CPT II activity of more than 10% of the mean and homozygosity for the common mutation S113L are usually associated with a milder reduction of long-chain fatty acid oxidation to about 80% of the control and with a later age of clinical onset. The early clinical presentation in the present patient is unique and was associated with a marked impairment of long-chain fatty acid oxidation, possibly because of other genetic factors. CPT II deficiency should be included in the differential diagnosis of isolated myoglobinuria in infancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10738923     DOI: 10.1016/s0887-8994(99)00125-3

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  9 in total

Review 1.  Carnitine palmitoyltransferase II deficiency with a focus on newborn screening.

Authors:  Go Tajima; Keiichi Hara; Miori Yuasa
Journal:  J Hum Genet       Date:  2018-12-04       Impact factor: 3.172

Review 2.  Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism.

Authors:  Sander M Houten; Ronald J A Wanders; Pablo Ranea-Robles
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-02-10       Impact factor: 5.187

3.  Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry.

Authors:  K Gempel; S Kiechl; S Hofmann; H Lochmüller; U Kiechl-Kohlendorfer; J Willeit; W Sperl; A Rettinger; I Bieger; D Pongratz; K D Gerbitz; M F Bauer
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

4.  Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4.

Authors:  Sara Violante; Nihad Achetib; Carlo W T van Roermund; Jacob Hagen; Tetyana Dodatko; Frédéric M Vaz; Hans R Waterham; Hongjie Chen; Myriam Baes; Chunli Yu; Carmen A Argmann; Sander M Houten
Journal:  FASEB J       Date:  2018-12-12       Impact factor: 5.191

5.  Rhabdomyolysis and Cardiomyopathy in a 20-Year-Old Patient with CPT II Deficiency.

Authors:  M Vavlukis; A Eftimov; P Zafirovska; E Caparovska; B Pocesta; S Kedev; A J Dimovski
Journal:  Case Rep Genet       Date:  2014-01-20

Review 6.  Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.

Authors:  Diana Lehmann; Leila Motlagh; Dina Robaa; Stephan Zierz
Journal:  Int J Mol Sci       Date:  2017-01-03       Impact factor: 5.923

7.  Infantile onset carnitine palmitoyltransferase 2 deficiency: Cortical polymicrogyria, schizencephaly, and gray matter heterotopias in an adolescent with normal development.

Authors:  Ivan Shelihan; Elsa Rossignol; Jean-Claude Décarie; Jean-Paul Bonnefont; Michèle Brivet; Catherine Brunel-Guitton; Grant A Mitchell
Journal:  JIMD Rep       Date:  2021-09-29

8.  Mutation Spectrum of Primary Lipid Storage Myopathies.

Authors:  Seena Vengalil; Kiran Polavarapu; Veeramani Preethish-Kumar; Saraswati Nashi; Gautham Arunachal; Tanushree Chawla; Mainak Bardhan; Dhaarini Mohan; Rita Christopher; Nandeesh Bevinahalli; Karthik Kulanthaivelu; Ichizo Nishino; Mohammad Faruq; Atchayaram Nalini
Journal:  Ann Indian Acad Neurol       Date:  2022-02-01       Impact factor: 1.383

Review 9.  Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach.

Authors:  Pushpa Raj Joshi; Stephan Zierz
Journal:  Molecules       Date:  2020-04-13       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.